コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (DAMP) signals derived from conditioning and intestinal microbiota.
2 from culturable bacteria) and ARDs from the intestinal microbiota.
3 n because of their inability to compete with intestinal microbiota.
4 s may play a role in sleep modulation by the intestinal microbiota.
5 logue of 3.9 million proteins from the human intestinal microbiota.
6 pplicability of new strategies targeting the intestinal microbiota.
7 ning and accompanying diversification of the intestinal microbiota.
8 te, reaches the colon to be fermented by the intestinal microbiota.
9 ve treatments that significantly disrupt the intestinal microbiota.
10 ated intestinal fibrosis without influencing intestinal microbiota.
11 tion of the diversity and composition of the intestinal microbiota.
12 ted responses of human CD4(+) T cells to the intestinal microbiota.
13 Here, we investigated the involvement of intestinal microbiota.
14 ave been shown to be vital components of the intestinal microbiota.
15 ted with host antigens, including autologous intestinal microbiota.
16 ed in human bipolar disorder, and changes in intestinal microbiota.
17 cooperative phenotypes within the mammalian intestinal microbiota.
18 ents in the establishment/maintenance of the intestinal microbiota.
19 tion of proteomics for functional studies of intestinal microbiota.
20 uman health benefits via their impact on the intestinal microbiota.
21 the gut, where their presence depends on the intestinal microbiota.
22 tibility to vancomycin-induced alteration of intestinal microbiota.
23 enefits of breastfeeding are conveyed by the intestinal microbiota.
24 and intestinal humoral responses and select intestinal microbiota.
25 this phenotype requires the presence of the intestinal microbiota.
26 cifically reduce the virome component of the intestinal microbiota.
27 n influencing the community structure of the intestinal microbiota.
28 mucosal surfaces and coats a fraction of the intestinal microbiota.
29 ic immune responses can be influenced by the intestinal microbiota.
30 g enterococci or between enterococci and the intestinal microbiota.
31 in has more impact than ciprofloxacin on the intestinal microbiota.
32 ids, the intestinal immune response, and the intestinal microbiota.
33 s to life in the cold are facilitated by the intestinal microbiota.
34 One possible modulator could be the intestinal microbiota.
35 acted from mouse fecal samples to assess the intestinal microbiota.
36 gnificantly affecting the structure of their intestinal microbiota.
37 s gnavus E1, a symbiont of the healthy human intestinal microbiota.
38 unopathological processes in response to the intestinal microbiota.
39 eptibility, the immune system, and commensal intestinal microbiota.
40 IBD and the potential to engineer patients' intestinal microbiota.
41 ported to be an important member of the host intestinal microbiota.
42 provides a method for precisely editing the intestinal microbiota.
43 ion by modulating the host's response to the intestinal microbiota.
44 nomic and functional characterization of the intestinal microbiota.
45 ied how exocrine pancreatic function affects intestinal microbiota.
46 AD patients have altered intestinal microbiota.
47 of a colon in continuity, and preserving the intestinal microbiota.
48 lcholine (PtC), or antigens expressed by the intestinal microbiota.
49 We showed considerable shifts within the intestinal microbiota 14-24 d postweaning in mice that w
50 the literature, particularly regarding small intestinal microbiota abundance and diversity, highlight
51 a2g1b by epithelial cells was dependent upon intestinal microbiota, adaptive immunity, and common-gam
52 he complex interactions between diet and the intestinal microbiota affect development of mucosal infl
53 recede arthritis, and that modulation of the intestinal microbiota after the onset of arthritis may o
55 addition to pathogenic infections, commensal intestinal microbiota also has numerous significant immu
56 at additional environmental factors, such as intestinal microbiota alterations, are involved in its p
57 gs identify previously unknown links between intestinal microbiota alterations, circulating amino aci
58 al peptides, which leads to dysbiosis of the intestinal microbiota, alters the mucosal barrier, and p
59 fh cells demonstrated that they required the intestinal microbiota and a diverse repertoire of CD4(+)
60 (IBD) is characterized by alterations in the intestinal microbiota and altered immune responses to gu
62 te that environmental factors, including the intestinal microbiota and changes in diet, can alter nor
63 e association between the composition of the intestinal microbiota and clinical features of irritable
64 e association between the composition of the intestinal microbiota and clinical features of irritable
65 pacts of metronidazole and vancomycin on the intestinal microbiota and colonization resistance are un
66 antibiotic administration, which changes the intestinal microbiota and compromises resistance to colo
67 significant and long-lasting effects on the intestinal microbiota and consequently reduce colonizati
69 growth stunting and components of the small intestinal microbiota and enteropathy and offer a ration
70 nces will allow clinicians to manipulate the intestinal microbiota and guide patient management in pa
72 100A8 and S100A9 regulate development of the intestinal microbiota and immune system in neonates.
73 erses the impact of Western diet (WD) on the intestinal microbiota and improves postoperative surviva
74 ecific differences in the composition of the intestinal microbiota and in susceptibility to metabolic
75 orbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade infla
78 vailability of l-arginine as well as altered intestinal microbiota and metabolic products accounts fo
81 information on the functional activities of intestinal microbiota and on host-microbe interactions a
83 of orally infected mice that alters the host intestinal microbiota and promotes intestinal colonizati
84 , we discuss the novel and emerging field of intestinal microbiota and roles of gut permeability and
85 nd a prebiotic (OI) to selectively alter the intestinal microbiota and significantly reduce body weig
86 during early larval development requires the intestinal microbiota and that specific bacterial member
87 e association between the composition of the intestinal microbiota and the development of allergic di
88 eview summarizes the association between the intestinal microbiota and the development of allergic se
89 ew of the interactions occurring between the intestinal microbiota and the immune system, and we will
90 tion alters the composition of the bacterial intestinal microbiota and, conversely, that the presence
93 intestinal epithelial barrier function, the intestinal microbiota, and cytokine signaling in the pat
94 n humans, TMA is produced exclusively by the intestinal microbiota, and its metabolite, trimethylamin
95 bacter pylori, other members of the neonatal intestinal microbiota, and microbial peptides and metabo
96 ge, and the serum IgG response to a panel of intestinal microbiota antigens was assessed by using a n
97 lationship between the host and its resident intestinal microbiota, appropriate mucosal T cell respon
98 r, our results indicate that the majority of intestinal microbiota ARDs can be considered intrinsic t
100 hether bacterial and viral components of the intestinal microbiota are associated with this phenomeno
102 ested the hypothesis that alterations in the intestinal microbiota are linked with the progression of
103 ed on geographic and cultural differences in intestinal microbiota are necessary to define applicabil
104 responses directed against antigens from the intestinal microbiota are observed in certain diseases,
105 alterations to the structure and function of intestinal microbiota are sufficient to promote the meta
108 summary a 3-day juice-based diet altered the intestinal microbiota associated with weight loss, incre
111 data also demonstrate that disruption of the intestinal microbiota by antibiotic treatment prevents p
112 flore), in 20 of the 64 NICUs, analyzed the intestinal microbiota by culture and 16S ribosomal RNA g
117 est whether the perioperative composition of intestinal microbiota can contribute to variable outcome
118 y have confirmed that the composition of the intestinal microbiota can imprint susceptibility or resi
121 bjects with moderate genetic susceptibility, intestinal microbiota changes may be a factor that incre
122 wth failure have disrupted maturation of the intestinal microbiota, characterized by persistently low
123 olatile organic compounds (VOCs), reflecting intestinal microbiota composition and function, allow fo
124 ptibilities, and the potential of modulating intestinal microbiota composition and metabolism as a no
125 ve contributions of each of these factors on intestinal microbiota composition following VSG prior to
127 SG resulted in weight loss and shifts in the intestinal microbiota composition relative to sham-opera
128 sed the relation between feeding strategies, intestinal microbiota composition, and the development o
130 e gastrointestinal tract is regulated by the intestinal microbiota composition, particularly the pres
131 d intestinal permeability and changes in the intestinal microbiota composition, which contribute to t
132 on was associated with significantly altered intestinal microbiota composition, which was linked to a
136 fied the Bacteroides2 (Bact2) enterotype, an intestinal microbiota configuration that is associated w
138 ctions between the mucosal immune system and intestinal microbiota contribute to pathogenesis of infl
140 ize that generation of this biopterin by the intestinal microbiota contributes to its tissue increase
144 nt metronidazole, are associated with marked intestinal microbiota destruction and greater risk of co
146 pectrum antibiotic treatment (to deplete the intestinal microbiota) did not alter the responses in Nr
147 sed vessel density, compositional changes in intestinal microbiota, diminished infiltration by myeloi
148 biotransformation of host metabolites by the intestinal microbiota directly and regionally impacts in
152 host mild but significant differences in the intestinal microbiotas during a critical early window of
155 l cancer cell colonization or proliferation, intestinal microbiota effects, or tumoricidal activity b
156 aiotaomicron, a dominant member of the human intestinal microbiota, encodes polysaccharide utilizatio
157 ence has accumulated to demonstrate that the intestinal microbiota enhances mammalian enteric virus i
160 ronment, which suggests major changes in the intestinal microbiota following movement to saltwater.
166 ough April 2, 2018 for studies that compared intestinal microbiota (from fecal or colonic or ileal ti
167 standing how the mammalian immune system and intestinal microbiota functionally interact have yielded
170 experimental evidence demonstrates that the intestinal microbiota has an important impact on pancrea
178 Hydrogen sulfide (H(2)S) production in the intestinal microbiota has many contributions to human he
179 s is well studied, its impact on shaping the intestinal microbiota has not been addressed in depth.
181 mmune response, intestinal inflammation, and intestinal microbiota have been established, many gaps i
182 ions in the composition and functions of the intestinal microbiota have been implicated in multiple d
186 urinary 3-indoxyl sulfate is a biomarker of intestinal microbiota health and predicts reduced intest
187 to lead to durable alterations to the murine intestinal microbiota, ileal gene expression, specific i
189 cular, experimental manipulations that alter intestinal microbiota impact exploratory and communicati
191 jective was to identify early differences in intestinal microbiota in a cohort of breastfeeding infan
194 ids in fecal samples, and composition of the intestinal microbiota in children with overweight or obe
195 licated in changes in the composition of the intestinal microbiota in Crohn's disease, but its role o
197 tive cancer, supporting a potential role for intestinal microbiota in mediating the association betwe
198 ions of fenugreek remain unknown, a role for intestinal microbiota in metabolic homeostasis is likely
199 This review discusses the roles of human intestinal microbiota in normal physiology, their associ
200 amentous bacteria (sfb), but the role of the intestinal microbiota in pulmonary host defense is not w
201 supporting the important role for early-life intestinal microbiota in the development of childhood as
202 have produced evidence for a causal role of intestinal microbiota in the etiology of obesity and ins
204 cent studies uncovered significant roles for intestinal microbiota in this process, but underlying me
206 tients without a C-seal can be linked to the intestinal microbiota, in particular with a low microbia
208 It was our hypothesis that changes in the intestinal microbiota induced by a juice-based diet play
212 es in the diet can affect the interaction of intestinal microbiota influencing the immune system, whi
213 hogens and changes in the composition of the intestinal microbiota initiate this process, which leads
219 better understand how the composition of the intestinal microbiota is connected to risk of gram-negat
223 tiple antibiotics, tend to colonize when the intestinal microbiota is dysbiotic, and elicit a severe
226 Moreover, it is now well admitted that the intestinal microbiota is involved in shaping and maturat
230 s aureus and Staphylococcus epidermidis) and intestinal microbiota (Lactobacillus reuteri, Enterococc
231 odulatory activity or through effects on the intestinal microbiota leading to reduced microbial trans
232 we present a pipeline for the assessment of intestinal microbiota localization within immunofluoresc
233 , chronic infections and disturbances in the intestinal microbiota; low-grade mucosal inflammation, i
234 These observations suggest that altered intestinal microbiota may be associated with disease sus
235 An emerging body of work suggests that the intestinal microbiota may help to explain some of these
237 A recent study suggested that early-life intestinal microbiota may play an important role in the
240 sulitis, an effect that was dependent on the intestinal microbiota; moreover, they developed autoimmu
241 hough both Toll and IMD effectors controlled intestinal microbiota, neither affected Trypanosoma cruz
243 east 50-60% of the bacterial genera from the intestinal microbiota of a healthy individual produce re
245 It is not clear whether alterations in the intestinal microbiota of children with celiac disease (C
248 ibosomal RNA gene sequencing to characterize intestinal microbiota of free-ranging sympatric chimpanz
257 ause accumulating evidence has revealed that intestinal microbiota play an important role in human he
263 s have described how helminths may alter the intestinal microbiota, potentially representing a mechan
264 o assess the adaptive immune response to the intestinal microbiota present in 143 healthy adults and
267 BS and healthy individuals, we identified an intestinal microbiota profile that is associated with th
272 odeficient or chemotherapy-treated mice, the intestinal microbiota provides nonredundant defense agai
273 ngs provide mechanistic insight into how the intestinal microbiota regulates body composition and est
274 next-generation probiotics derived from the intestinal microbiota represents an alternative approach
275 ommunity of commensal microbes, known as the intestinal microbiota, resides within the gastrointestin
276 Further, 16S rRNA sequence analysis of the intestinal microbiota revealed marked changes in the com
277 Inhibition of FPRL1, but not suppression of intestinal microbiota, reversed these protective effects
280 ation of copper in the GI tract of mice with intestinal microbiota significantly depleted by antibiot
284 which lack all NKT cells, harbor an altered intestinal microbiota that is associated with exacerbate
285 icobacter hepaticus is a member of the mouse intestinal microbiota that is tolerated by the host.
287 deplete commensal bacterial strains from the intestinal microbiota, thereby reducing colonization res
288 guts, SCFAs are mostly produced by anaerobic intestinal microbiota through the fermentation of dietar
289 potential therapeutic power of manipulating intestinal microbiota to ensure host metabolic health an
290 in vitro studies of the contribution of the intestinal microbiota to infectious disease are discusse
291 in ECs senses single-strand RNA (ssRNA) from intestinal microbiota to promote serotonin production.
298 (reg) cells led to profound dysbiosis of the intestinal microbiota, which when transferred to germ-fr
300 AIMS: It might be possible to manipulate the intestinal microbiota with prebiotics or other agents to